Eva Rohde MD
Director GMP Unit and Head of the Department of Transfusion Medicine
Paracelsus Medical University Salzburg
Salzburg
Austria
|
Eva Rohde, MD, is Head of the Clinical Department of Transfusion Medicine at the University Hospital Salzburg, Austria, and Director of the first academic pharmaceutical manufacturing unit for stem cell- and extracellular vesicle-based therapeutics in Europe. Her research at the Paracelsus Medical University (PMU) in Salzburg focuses on the clinical application of stem cell-based therapies with a special emphasis on their extracellular vesicles (EVs). The overarching goal is to develop novel cell-free therapies in conjunction with scientifically solid application-oriented analytical technologies. Eva Rohde actively participates in a global network of academic and industrial partners with the goal of the clinical development of EV-based therapies in diseases with a high unmet need. Eva Rohde chairs the global “Task Force on Regulatory Affairs and Clinical Use of EV-based Therapeutics” of the International Society for Extracellular Vesicles (ISEV) and is a member of the ISCT Exosome Committee.